Fig. 4From: Pediatric subset of primary immunodeficiency patients treated with SCIG: post hoc analysis of SHIFT and IBIS pooled dataType and distribution of 8 non-SBI in 6/11 Q1W patients and 35 non-SBI in 10/13 Q2W patients. Q1W weekly administration, i.e., data from the SHIFT study, Q2W biweekly administration, i.e., data from the IBIS studyBack to article page